Millennium Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-386,546
| Closed | -$7.52M | – | 4445 |
|
|
2018
Q1 | $7.52M | Buy |
386,546
+352,704
| +1,042% | +$6.92M | 0.01% | 1531 |
|
|
2017
Q4 | $563K | Sell |
33,842
-245,273
| -88% | -$4.5M | ﹤0.01% | 3030 |
|
|
2017
Q3 | $5.67M | Sell |
279,115
-156,854
| -36% | -$3M | 0.01% | 1602 |
|
|
2017
Q2 | $7.02M | Sell |
435,969
-1,970,801
| -82% | -$29.1M | 0.01% | 1276 |
|
|
2017
Q1 | $30.4M | Buy |
2,406,770
+2,206,755
| +1,103% | +$26.7M | 0.06% | 493 |
|
|
2016
Q4 | $2.65M | Buy |
200,015
+150,015
| +300% | +$2.56M | 0.01% | 1716 |
|
|
2016
Q3 | $1.19M | Sell |
50,000
-293,809
| -85% | -$7.9M | ﹤0.01% | 2191 |
|
|
2016
Q2 | $9.91M | Sell |
343,809
-279,049
| -45% | -$9.1M | 0.02% | 856 |
|
|
2016
Q1 | $19.9M | Sell |
622,858
-75,098
| -11% | -$2.64M | 0.05% | 482 |
|
|
2015
Q4 | $29.8M | Buy |
697,956
+308,301
| +79% | +$12.3M | 0.06% | 424 |
|
|
2015
Q3 | $13.7M | Sell |
389,655
-172,128
| -31% | -$7.75M | 0.03% | 760 |
|
|
2015
Q2 | $25.8M | Buy |
561,783
+204,457
| +57% | +$9.7M | 0.05% | 503 |
|
|
2015
Q1 | $16.7M | Sell |
357,326
-47,270
| -12% | -$1.88M | 0.03% | 754 |
|
|
2014
Q4 | $12.8M | Buy |
404,596
+265,703
| +191% | +$7.78M | 0.03% | 845 |
|
|
2014
Q3 | $3.29M | Sell |
138,893
-198,997
| -59% | -$5.1M | 0.01% | 1552 |
|
|
2014
Q2 | $10.1M | Sell |
337,890
-846,835
| -71% | -$22.8M | 0.03% | 813 |
|
|
2014
Q1 | $31.3M | Buy |
1,184,725
+471,171
| +66% | +$11.8M | 0.09% | 276 |
|
|
2013
Q4 | $17.9M | Sell |
713,554
-216,842
| -23% | -$4.84M | 0.06% | 408 |
|
|
2013
Q3 | $19M | Sell |
930,396
-211,430
| -19% | -$4.37M | 0.06% | 371 |
|
|
2013
Q2 | $22.8M | Buy |
+1,141,826
| New | +$20.3M | 0.07% | 259 |
|
Millennium Management's IPXL Position: Q2 2018 in Review
Millennium Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 386,546 shares — an estimated $7.52M sold.
Millennium Management first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $31.3M in Q1 2014. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Millennium Management reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Millennium Management sold 386,546 Impax Laboratories, Inc. shares in Q2 2018, an estimated $7.52M.
- Millennium Management first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Millennium Management's Impax Laboratories, Inc. position peaked at $31.3M in Q1 2014.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Millennium Management's 13F filing for Q2 2018, filed 14 Aug 2018.